Study Focuses on Muscle Weakness in Patients with Charcot-Marie-Tooth Disease Type 1A
Pezibear / Pixabay

Study Focuses on Muscle Weakness in Patients with Charcot-Marie-Tooth Disease Type 1A

According to a story from Charcot-Marie-Tooth News, a recent study has revealed that patients with Charcot-Marie-Tooth disease (CMT) type 1A still display signs of muscle weakness even if they retain…

Continue Reading Study Focuses on Muscle Weakness in Patients with Charcot-Marie-Tooth Disease Type 1A

Steadman Philippon Research Institute Receives Award for Duchenne Muscular Dystrophy Research

According to a story from Financial Buzz, the Steadman Philippon Research Institute (SPRI) recently received an award in research from the National Institutes of Health (NIH). The award is in…

Continue Reading Steadman Philippon Research Institute Receives Award for Duchenne Muscular Dystrophy Research

University of Missouri Dean Awarded $1 Million in Grants for Spinal Muscular Atrophy Research

According to a story from Mizzou News, Chris Lorson, who is the associate dean for Research and Graduate Studies at the school's College of Veterinary Medicine, recently earned four grants…

Continue Reading University of Missouri Dean Awarded $1 Million in Grants for Spinal Muscular Atrophy Research
ICYMI: Successful Phase 3 Study of Familial Chylomicronemia Syndrome Drug May Win Drug Approval in US
TeroVesalainen / Pixabay

ICYMI: Successful Phase 3 Study of Familial Chylomicronemia Syndrome Drug May Win Drug Approval in US

According to a publication from BioPortfolio, American biotechnology companies Akcea Therapeutics and Ionis Pharmaceuticals recently published final study results from their phase 3 clinical study of Waylivra (generic name volanesorsen)…

Continue Reading ICYMI: Successful Phase 3 Study of Familial Chylomicronemia Syndrome Drug May Win Drug Approval in US
Combination Treatment for Chronic Lymphocytic Leukemia to Soon be Covered on the NHS in Scotland
FrankWinkler / Pixabay

Combination Treatment for Chronic Lymphocytic Leukemia to Soon be Covered on the NHS in Scotland

According to a story from Cancer Research UK, a combination treatment featuring the targeted cancer therapy venetoclax (marketed as Venclyxto) and the monoclonal antibody rituximab will soon be covered by…

Continue Reading Combination Treatment for Chronic Lymphocytic Leukemia to Soon be Covered on the NHS in Scotland

New Study Finds Genetic Instability in Brain Cells as Key Trigger for Huntington’s Disease

According to a story from Medical Xpress, a recent study has determined that the onset of Huntington's disease symptoms is triggered by genetic instability in a specific sequence of DNA…

Continue Reading New Study Finds Genetic Instability in Brain Cells as Key Trigger for Huntington’s Disease
This Form of Rare Interstitial Lung Disease is Bad News for Scleroderma Patients
kalhh / Pixabay

This Form of Rare Interstitial Lung Disease is Bad News for Scleroderma Patients

According to a story from Scleroderma News, a recent study has recommended that scleroderma patients with a rare, poorly understood form of interstitial lung disease (ILD) should receive regular monitoring…

Continue Reading This Form of Rare Interstitial Lung Disease is Bad News for Scleroderma Patients